Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Still Guilty: Three Former Purdue Execs Lose Fight To Overturn Their Exclusion From Gov't Programs

This article was originally published in The Pink Sheet Daily

Executive Summary

"As with plaintiffs' repeated attempts to characterize themselves as innocent third parties to Purdue's misbranding, the court finds plaintiffs' arguments with respect to financial loss reflective of a fundamental misconception of their own plea agreements," the ruling states.

You may also be interested in...



Prison Terms For Corporate Officers Over Food Violations Worry Pharma

Appeals court affirms sentencing of executives who pled guilty to FDCA misdemeanor violations for distribution of salmonella-contaminated eggs; split ruling finds that officers don't need to know they were violating law to be subject to imprisonment.

Acquittal Of Former Warner Chilcott Exec May Make Future Prosecutions More Difficult

Boston jury clears Carl Reichel of conspiring to pay kickbacks to physicians in case involving dinners and speaker fees.

Purdue Execs’ Exclusion Stands But Court Tells HHS To Justify 12-Year Term

The question now is whether HSS Secretary Sebelius will provide a rationale to continue the 12-year exclusion or reduce the length of the exclusion; appeals court upholds HHS’s authority to exclude three former Purdue Pharma executives from federal health care programs, but notes the length of the sanction departs from similar cases.

Related Content

Topics

UsernamePublicRestriction

Register

GB150348

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel